Laboratorio Reig Jofre S.A. | Mid-cap | Healthcare

Laboratorio Reig Performance Comparison

Loading chart data...

Stock Range

Today's Range

Low: €2.95 High: €3.02
on August 8, 2025

52 Week Range

Low: €2.46 High: €3.40
on January 16, 2025
on June 6, 2025

All-Time High: €55.00 on November 25, 2002

Explore how other Spanish stocks compare to their 52-week ranges: View ES Market 52-Week Insights

Key Statistics

Market Cap i €240.1M
EPS i 0.07
P/E Ratio (TTM) i 42.14
Forward P/E i 14.05
P/B Ratio i 1.10
PEG Ratio i 14.05
Div. Yield i 1.61%
ROE i 3.03%
Beta i 0.790
Debt to Equity i 31.04

Financial Highlights

Profitability

Gross Margin i 58.43%
Operating Margin i -2.52%
Profit Margin i 1.89%

Returns and Earnings

Return on Assets (TTM) i 1.49%
Return on Equity (TTM) i 3.03%
EBITDA i €48.2M
Net Income (TTM) i €6.4M

Growth

Revenue (TTM) i
Revenue Per Share (TTM) i €4.20
Quarterly Revenue Growth (YoY) i -9.00%
Quarterly Earnings Growth (YoY) i 110.83%

Dividend Information

Last 12-Month Dividend i €0.05
Current Dividend Yield i 1.61%
3-Year Average Dividend Yield i 8.04%
3-Year Average Annual Dividend i €0.38
3-Year Total Dividends i €1.13
Ex-Dividend Date i May 15, 2025

Peer Performance Comparison

Performance comparison table showing returns for peer companies over various time periods
CompanyMarket Cap1W1M3M6MYTD1Y3Y5Y
Laboratorio Reig RJF 240.10M Mid-cap2.03%1.68%1.00%14.83%17.51%9.49%8.70%-20.84%
Laboratorios ROVI 2.72B Large-cap-2.03%-3.37%3.41%-4.32%-17.03%-32.16%1.36%86.38%
Almirall S.A ALM 2.20B Large-cap-3.21%-4.12%0.20%13.15%22.20%14.03%4.28%7.11%
Faes Farma S.A FAE 1.31B Large-cap-3.21%-5.80%-0.24%15.30%20.23%19.89%7.11%21.97%
Labiana Health S.A LAB 28.16M Small-cap4.32%15.57%19.14%33.10%31.29%22.58%6,233.33%1,051.52%
Grifols, S.A GRF 7.93B Large-cap-2.06%22.50%57.28%54.08%35.84%46.52%-6.61%-47.55%

Ownership & Short Interest

Insider Ownership i 77.76%
Institutional Ownership i 4.21%
Shares Short i N/A
Short Ratio i N/A
Short % of Shares Outstanding i N/A
Average 10-Day Volume i 21K
Average 90-Day Volume i 19K

Laboratorio Reig Recurring Investment / Dollar-Cost Averaging Calculator

Calculate how a regular investment in Laboratorio Reig would have performed over time.

If not specified, the latest available data will be used

Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.

Frequently Asked Questions

In the last 52 weeks, Laboratorio Reig reached a high of €3.40 (on June 6, 2025) and a low of €2.46 (on January 16, 2025).
Curious about Laboratorio Reig's size and valuation? Its market capitalization stands at 240.10M. When it comes to valuation, the P/E ratio (trailing twelve months) is 42.14, and the forward P/E (looking ahead) is 14.05.
Yes, Laboratorio Reig is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 1.61%, and the company has paid an average of €0.38 per share annually over the past 3 years.

When looking at Laboratorio Reig, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

CompanyMkt CapSectorIndustry1Y Return3Y Return
Laboratorios
ROVI
2.72BHealthcareDrug Manufacturers - Specialty & Generic-32.16%1.36%
Almirall S.A
ALM
2.20BHealthcareDrug Manufacturers - Specialty & Generic14.03%4.28%
Faes Farma S.A
FAE
1.31BHealthcareDrug Manufacturers - Specialty & Generic19.89%7.11%
Labiana Health S.A
LAB
28.16MHealthcareDrug Manufacturers - Specialty & Generic22.58%6,233.33%
Grifols, S.A
GRF
7.93BHealthcareDrug Manufacturers - General46.52%-6.61%

For a more comprehensive list, please see the Peer Performance Comparison table on this page.

To get a sense of Laboratorio Reig's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 3.03%, the Debt to Equity ratio from the most recent quarter is 31.04, and its Gross Profit Margin stands at 58.43%.
Looking at Laboratorio Reig's growth, its revenue over the trailing twelve months (TTM) was €336M. Compared to the same quarter last year (YoY), quarterly revenue grew by -9.00%, and quarterly earnings saw a YoY growth of 110.83%.
Wondering who owns Laboratorio Reig stock? Company insiders (like executives and directors) hold about 77.76% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 4.21%.

For more common questions about our data, please visit our About Data page.

Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.